Avlar BioVentures

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

Takeda Cambridge specializes in developing oral diabetes medications.

NXVISION is a web platform that allows users to create blogs, promote businesses, and build web sites for personal use.

Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair.

Amura is a structure-based drug discovery business specializing in diseases such as osteoporosis, osteoarthritis, malaria, and more.

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

Takeda Cambridge specializes in developing oral diabetes medications.

Purely Proteins Limited, an innovative, informatics-led protein purification company based in Cambridge, UK.